rs773512610

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_181882.3(PRX):​c.4121T>G​(p.Val1374Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000649 in 1,603,266 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000066 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000065 ( 1 hom. )

Consequence

PRX
NM_181882.3 missense

Scores

1
18

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.97

Publications

1 publications found
Variant links:
Genes affected
PRX (HGNC:13797): (periaxin) This gene encodes a protein involved in peripheral nerve myelin upkeep. The encoded protein contains 2 PDZ domains which were named after PSD95 (post synaptic density protein), DlgA (Drosophila disc large tumor suppressor), and ZO1 (a mammalian tight junction protein). Two alternatively spliced transcript variants have been described for this gene which encode different protein isoforms and which are targeted differently in the Schwann cell. Mutations in this gene cause Charcot-Marie-Tooth neuoropathy, type 4F and Dejerine-Sottas neuropathy. [provided by RefSeq, Jul 2008]
PRX Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 4
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Charcot-Marie-Tooth disease type 4F
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • Charcot-Marie-Tooth disease type 3
    Inheritance: AD, AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0354425).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRXNM_181882.3 linkc.4121T>G p.Val1374Gly missense_variant Exon 7 of 7 ENST00000324001.8 NP_870998.2
PRXNM_001411127.1 linkc.4406T>G p.Val1469Gly missense_variant Exon 7 of 7 NP_001398056.1
PRXXM_017027047.2 linkc.4019T>G p.Val1340Gly missense_variant Exon 4 of 4 XP_016882536.1
PRXNM_020956.2 linkc.*4326T>G 3_prime_UTR_variant Exon 6 of 6 NP_066007.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRXENST00000324001.8 linkc.4121T>G p.Val1374Gly missense_variant Exon 7 of 7 1 NM_181882.3 ENSP00000326018.6

Frequencies

GnomAD3 genomes
AF:
0.0000662
AC:
10
AN:
151166
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000244
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000569
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000443
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000156
AC:
38
AN:
244366
AF XY:
0.000143
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000879
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000517
Gnomad NFE exome
AF:
0.000209
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000647
AC:
94
AN:
1452100
Hom.:
1
Cov.:
30
AF XY:
0.0000708
AC XY:
51
AN XY:
720618
show subpopulations
African (AFR)
AF:
0.0000900
AC:
3
AN:
33318
American (AMR)
AF:
0.0000677
AC:
3
AN:
44282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25788
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39438
South Asian (SAS)
AF:
0.0000467
AC:
4
AN:
85626
European-Finnish (FIN)
AF:
0.000489
AC:
26
AN:
53144
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5718
European-Non Finnish (NFE)
AF:
0.0000453
AC:
50
AN:
1104910
Other (OTH)
AF:
0.0000668
AC:
4
AN:
59876
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000662
AC:
10
AN:
151166
Hom.:
0
Cov.:
33
AF XY:
0.0000813
AC XY:
6
AN XY:
73782
show subpopulations
African (AFR)
AF:
0.0000244
AC:
1
AN:
40992
American (AMR)
AF:
0.00
AC:
0
AN:
15202
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5112
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4774
European-Finnish (FIN)
AF:
0.000569
AC:
6
AN:
10546
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000443
AC:
3
AN:
67780
Other (OTH)
AF:
0.00
AC:
0
AN:
2070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.545
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000605
Hom.:
0
ExAC
AF:
0.000198
AC:
24

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Charcot-Marie-Tooth disease type 4 Uncertain:1
Jun 13, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces valine, which is neutral and non-polar, with glycine, which is neutral and non-polar, at codon 1374 of the PRX protein (p.Val1374Gly). This variant is present in population databases (rs773512610, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with PRX-related conditions. ClinVar contains an entry for this variant (Variation ID: 476970). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The glycine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
0.039
DANN
Benign
0.76
DEOGEN2
Benign
0.17
T
Eigen
Benign
-2.3
Eigen_PC
Benign
-2.3
FATHMM_MKL
Benign
0.039
N
LIST_S2
Benign
0.13
T
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.035
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
0.14
N
PhyloP100
-2.0
PrimateAI
Uncertain
0.61
T
PROVEAN
Benign
-1.4
N
REVEL
Benign
0.032
Sift
Benign
0.11
T
Sift4G
Benign
0.54
T
Polyphen
0.0
B
Vest4
0.16
MutPred
0.40
Loss of stability (P = 0.0074);
MVP
0.085
MPC
0.29
ClinPred
0.038
T
GERP RS
-5.6
Varity_R
0.066
gMVP
0.56
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs773512610; hg19: chr19-40900138; API